DNAPrint Genomics Alpha and Beta Analysis

This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as DNAPrint Genomics. It also helps investors analyze the systematic and unsystematic risks associated with investing in DNAPrint Genomics over a specified time horizon. Remember, high DNAPrint Genomics' alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to DNAPrint Genomics' market risk premium analysis include:
Beta
0.0
Alpha
0.0
Risk
0.0
Sharpe Ratio
0.0
Expected Return
0.0
Please note that although DNAPrint Genomics alpha is a measure of relative return and represented here as a single number, it indicates the percentage above or below your selected benchmark (i.e., Dow Jones Industrial index.) So in this particular case, DNAPrint Genomics did 0.00  better than the index. Remember, a high alpha is always good. Beta, on the other hand, measures the volatility (or risk) of an investment. It is an indication of DNAPrint Genomics stock's relative risk over its benchmark. DNAPrint Genomics has a beta of 0.00  . The returns on DOW JONES INDUSTRIAL and DNAPrint Genomics are completely uncorrelated. .
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
  
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

DNAPrint Genomics Market Premiums

Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. DNAPrint Genomics market risk premium is the additional return an investor will receive from holding DNAPrint Genomics long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in DNAPrint Genomics. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate DNAPrint Genomics' performance over market.
α0.00   β0.00

DNAPrint Genomics Fundamentals Vs Peers

Comparing DNAPrint Genomics' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze DNAPrint Genomics' direct or indirect competition across all of the common fundamentals between DNAPrint Genomics and the related equities. This way, we can detect undervalued stocks with similar characteristics as DNAPrint Genomics or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of DNAPrint Genomics' fundamental indicators could also be used in its relative valuation, which is a method of valuing DNAPrint Genomics by comparing valuation metrics with those of similar companies.
    
 Better Than Average     
    
 Worse Than Average Compare DNAPrint Genomics to competition
FundamentalsDNAPrint GenomicsPeer Average
Return On Asset-1.05-0.14
Profit Margin(2.36) %(1.27) %
Operating Margin(7.31) %(5.51) %
Current Valuation5.21 M16.62 B
Shares Outstanding644.61 M571.82 M
Shares Owned By Institutions0.18 %39.21 %
Price To Sales0.0003 X11.42 X

DNAPrint Genomics Opportunities

DNAPrint Genomics Return and Market Media

The Stock did not receive any noticable media coverage during the period.
 Price Growth (%)  
       Timeline  

About DNAPrint Genomics Beta and Alpha

For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including DNAPrint or other delisted stocks. Alpha measures the amount that position in DNAPrint Genomics has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards DNAPrint Genomics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, DNAPrint Genomics' short interest history, or implied volatility extrapolated from DNAPrint Genomics options trading.

Build Portfolio with DNAPrint Genomics

Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.

Build Diversified Portfolios

Align your risk with return expectations

By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.

Other Consideration for investing in DNAPrint Stock

If you are still planning to invest in DNAPrint Genomics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the DNAPrint Genomics' history and understand the potential risks before investing.
Stocks Directory
Find actively traded stocks across global markets
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum